Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research.

CES1 CES2 CYP3A4 P-glycoprotein PEPT1 intestinal first-pass effect intestinal organoids microarray monolayer culture small intestine

Journal

Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857

Informations de publication

Date de publication:
10 Sep 2021
Historique:
received: 09 02 2021
accepted: 11 05 2021
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 7 9 2021
Statut: epublish

Résumé

The human small intestine is the key organ for absorption, metabolism, and excretion of orally administered drugs. To preclinically predict these reactions in drug discovery research, a cell model that can precisely recapitulate the

Identifiants

pubmed: 34485610
doi: 10.1016/j.omtm.2021.05.005
pii: S2329-0501(21)00089-9
pmc: PMC8399089
doi:

Types de publication

Journal Article

Langues

eng

Pagination

263-278

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Nat Med. 2011 Sep 04;17(10):1225-7
pubmed: 21892181
Nature. 2016 Jan 14;529(7585):226-30
pubmed: 26762460
BMC Genomics. 2008 Dec 24;9:633
pubmed: 19108745
Elife. 2020 Jan 14;9:
pubmed: 31933478
Front Cell Infect Microbiol. 2020 Jun 09;10:272
pubmed: 32656095
Sci Rep. 2018 Feb 13;8(1):2871
pubmed: 29440725
Cell Stem Cell. 2018 Dec 6;23(6):787-793.e6
pubmed: 30526881
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Drug Metab Dispos. 2018 Nov;46(11):1572-1580
pubmed: 29615438
Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94
pubmed: 17125407
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Drug Metab Pharmacokinet. 2008;23(2):87-94
pubmed: 18445987
Drug Metab Dispos. 2014 Feb;42(2):250-6
pubmed: 24212377
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Drug Metab Dispos. 2018 Feb;46(2):166-177
pubmed: 29212823
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Drug Metab Dispos. 2006 May;34(5):880-6
pubmed: 16467132
Drug Discov Today. 2005 Mar 1;10(5):335-43
pubmed: 15749282
Nat Protoc. 2013 Dec;8(12):2471-82
pubmed: 24232249
Cell Mol Gastroenterol Hepatol. 2017 Mar 06;4(1):165-182.e7
pubmed: 29204504
Sci Rep. 2020 Apr 6;10(1):5989
pubmed: 32249832
Pharmacol Rev. 1999 Jun;51(2):135-58
pubmed: 10353984
Nat Protoc. 2011 Nov 10;6(12):1920-8
pubmed: 22082986
Nature. 2020 Jan;577(7789):260-265
pubmed: 31853061
Biotechniques. 2003 Feb;34(2):374-8
pubmed: 12613259
Nat Med. 2013 Jul;19(7):939-45
pubmed: 23727931
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Pharmaceutics. 2020 Apr 28;12(5):
pubmed: 32354111
Mucosal Immunol. 2015 Mar;8(2):352-61
pubmed: 25118165
Stem Cell Reports. 2017 Dec 12;9(6):1976-1990
pubmed: 29153987
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Drug Metab Dispos. 2005 Aug;33(8):1185-90
pubmed: 15908471
Drug Metab Dispos. 2014 Feb;42(2):257-63
pubmed: 24212378
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):395-411
pubmed: 18433344
Nature. 2011 Jan 20;469(7330):415-8
pubmed: 21113151
Nature. 2013 Mar 7;495(7439):65-9
pubmed: 23446353
Drug Metab Dispos. 2018 Nov;46(11):1497-1506
pubmed: 30135242
Methods Mol Biol. 2017;1612:97-105
pubmed: 28634937
Drug Metab Dispos. 2006 Oct;34(10):1734-41
pubmed: 16837570
PLoS Biol. 2019 Mar 27;17(3):e3000202
pubmed: 30917112
Nucleic Acids Res. 2003 Dec 15;31(24):e154
pubmed: 14654707
Gut. 2015 Jun;64(6):911-20
pubmed: 25007816
Adv Drug Deliv Rev. 1997 Sep 15;27(2-3):99-127
pubmed: 10837554
Nucleic Acids Res. 2010 Jan;38(Database issue):D792-9
pubmed: 19906719
Nat Med. 2015 Mar;21(3):256-62
pubmed: 25706875
Nature. 2011 Feb 3;470(7332):105-9
pubmed: 21151107
Development. 2012 Feb;139(3):488-97
pubmed: 22190634
Nature. 2016 Nov 24;539(7630):560-564
pubmed: 27851739

Auteurs

Tomoki Yamashita (T)

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University Osaka 565-0871, Japan.

Tatsuya Inui (T)

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Jumpei Yokota (J)

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Kentaro Kawakami (K)

Department of Gastroenterology and Hepatology, School of Medicine, Sapporo Medical University, Hokkaido 060-8556, Japan.
Department of Medical Oncology, Keiyukai Sapporo Hospital, Hokkaido 003-0027, Japan.

Gaku Morinaga (G)

Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co., Ltd., Hyogo 650-0047, Japan.

Masahito Takatani (M)

Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co., Ltd., Hyogo 650-0047, Japan.

Daisuke Hirayama (D)

Department of Gastroenterology and Hepatology, School of Medicine, Sapporo Medical University, Hokkaido 060-8556, Japan.

Ryuga Nomoto (R)

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Kohei Ito (K)

Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co., Ltd., Hyogo 650-0047, Japan.

Yunhai Cui (Y)

Department of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany.

Stephanie Ruez (S)

Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany.

Kazuo Harada (K)

Laboratory of Applied Environmental Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Wataru Kishimoto (W)

Department of Pharmacokinetics and Nonclinical Safety, Nippon Boehringer Ingelheim Co., Ltd., Hyogo 650-0047, Japan.

Hiroshi Nakase (H)

Department of Gastroenterology and Hepatology, School of Medicine, Sapporo Medical University, Hokkaido 060-8556, Japan.

Hiroyuki Mizuguchi (H)

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Laboratory of Hepatocyte Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
Global Center for Medical Engineering and Informatics, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University Osaka 565-0871, Japan.

Classifications MeSH